These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17562647)

  • 1. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches.
    Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A
    Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USTUR whole body case 0262: 33-y follow-up of PuO2 in a skin wound and associated axillary node.
    James AC; Sasser LB; Stuit DB; Wood TG; Glover SE; Lynch TP; Dagle GE
    Radiat Prot Dosimetry; 2007; 127(1-4):114-9. PubMed ID: 18227076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
    Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NCRP wound model: development and application.
    Guilmette RA; Durbin PW; Toohey RE; Bertelli L
    Radiat Prot Dosimetry; 2007; 127(1-4):103-7. PubMed ID: 17766262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K; Brey R; Miller S
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms.
    Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL
    Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model.
    Schadilov AE; Belosokhov MV; Levina ES
    Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of monitoring data for 239Pu accidentally injected via wound site based on the proposed NCRP wound model.
    Ishigure N
    Radiat Prot Dosimetry; 2007; 127(1-4):108-13. PubMed ID: 17561522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcium trisodium DTPA in rats with puncture wound contaminated by 90Y-chloride.
    Watanabe N; Tanada S; Sasaki Y
    Radiat Prot Dosimetry; 2005; 114(4):509-13. PubMed ID: 15899907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future radionuclide speciation studies in biological media.
    Ansoborlo E; Bion L; Doizi D; Moulin C; Lourenco V; Madic C; Cote G; Van der Lee J; Moulin V
    Radiat Prot Dosimetry; 2007; 127(1-4):97-102. PubMed ID: 17578878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four years of follow-up for a Hanford plutonium wound case.
    Carbaugh EH; Lynch TP; Antonio CL; Medina-Del Valle F
    Health Phys; 2010 Oct; 99(4):483-94. PubMed ID: 20838089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical action levels for chelation therapy in plutonium inhalation using nose swab.
    Kurihara O; Takada C; Takasaki K; Ito K; Momose T; Miyabe K
    Radiat Prot Dosimetry; 2007; 127(1-4):411-4. PubMed ID: 17567761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
    Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
    Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MADOR: a new tool to calculate decrease of effective doses in human after DTPA therapy.
    Fritsch P; Grémy O; Hurtgen C; Bérard P; Grappin L; Poncy JL
    Radiat Prot Dosimetry; 2011 Mar; 144(1-4):371-5. PubMed ID: 21131659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants.
    Grappin L; Berard P; Menetrier F; Carbone L; Courtay C; Castagnet X; Le Goff JP; Neron MO; Piechowski J
    Radiat Prot Dosimetry; 2007; 127(1-4):435-9. PubMed ID: 17940101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.